The Supply of Alliance Solus Pharmaceutical Products

Leidos Supply Ltd. intends to award a single source framework for the provision of Alliance Solus Pharmaceutical Products for the UK Ministry of Defence. The agreement will be for the duration of 3 years. It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32 (2)(b)(iii) of Directive 2014/24/EC of the European Parliament (Regulation 32(2)(b)(iii) of Public Contracts Regulations 2015). The Solus products contained within the proposed agreement are only available for purchase through a contract direct with Alliance Healthcare. Team Leidos/MoD reserve the right to include additional Alliance Solus products into the agreement that fall within the advertised CPV codes. The estimated 3-year value is £3,360,000 - £8,400,000 GBP.